comparemela.com

Sven Rohmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HERVOLUTION Therapeutics Appoints Biotech Builder J Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration

HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration

New yorkUnited statesEleanor cooperHana malikMary clarkRobert colemanJ robert colemanSven rohmannEuropean innovation council fundBioinnovation institute novo nordisk foundationStrategic communicationsChief executiveColeman phdHuman endogenous retroviralChief executive officerHuman endogenous retroviruses

Danish biotech startup secures €6M seed funding to tackle HERVs, prominent tumor-specific antigens

Copenhagen-based biotech startup InProTher has successfully raised €6 million in its seed round of funding. The investment comes from private investors and

Sven rohmannHamina patelHermann hauserFund boardEuropean innovation councilHuman endogenous retrovirusesChief medical officerChief executive officer

InProTher announces €6M seed funding for cancer immunotherapy drug

Danish early-stage biotech company InProTher has raised €6M seed funding from private investors to advance its lead drug candidate IPT001.

Hamina patelSven rohmannEuropean innovation councilBioinnovation instituteNovo nordisk foundationHuman endogenous retrovirusesJordi navalBio developmentsMarkets amp regulationsSolid tumor

InProTher Announces EUR 6M Seed Financing with the Participation of the European Innovation Council Fund to Develop First-In-Class Cancer Immunotherapy

/PRNewswire/ InProTher, an early-stage biotechnology company developing effective immunotherapies targeting the Human Endogenous Retroviruses (HERVs), today.

Sven rohmannHermann hauserHamina patelPrnewswire inprotherDrug developmentEuropean commissionFund boardEuropean innovation council fundBioinnovation institute novo foundationBioinnovation instituteStrategic fundNovo nordisk foundationEuropean innovation councilHuman endogenous retrovirusesChief medical officerChief executive officer

InProTher Raises EUR6M in Seed Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sven rohmannHamina patelNovo nordisk foundationEuropean innovation councilBioinnovation instituteHuman endogenous retrovirusesJordi navalChief executive officerChief medical officer

vimarsana © 2020. All Rights Reserved.